Reducing calories may help cognitive function in MS

Published Date: 02 Mar 2023

Multiple sclerosis patients who cut calories two days a week not only lost weight but also experienced better cognition and other benefits in a new study.

Read Full News

Latest News

Ionis Pharma Prices First FDA-approved Treatment for Alexander Disease At $285,000 Per Dose

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

New Migraine Prevention Guidelines Released

Updated migraine prevention guidelines recommend preventive treatment for patients with ≥ 4 migraine days per month and incorporate CGRP-targeted therapies into individualized treatment selection.

Novartis Pauses Trials Of Experimental Cell Therapy After Three Deaths

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral Palsy Linked to Gaps in Gynecologic Care

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

Borderline Personality: Evidence Has Evolved. Care Hasn’t

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

New Stroke Rehab Guideline Calls for Earlier, Broader Care

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Latest News

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

Updated migraine prevention guidelines recommend preventive treatment for patients with ≥ 4 migraine days per month and incorporate CGRP-targeted therapies into individualized treatment selection.

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

News All Time

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Inherited Alzheimer's risk didn't differ between superagers and cognitively average older adults

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Health news and commentary gathered by MedPage Today staff

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

Good things come to those who wait -- and to those who don't wait

FDA Approves Tylenol With Naproxen Combination

First OTC fixed-dose combination product to pair acetaminophen with naproxen sodium

FDA Panel Finds a Peptide It Doesn't Like

Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

MRI uncovers neurocysticercosis in a 52-year-old woman

First-in-Class Drug for ADHD Wins FDA Approval

Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older

FDA Scientists Raise Questions About Duchenne Drug

Agency says deramiocel did not meet phase III trial endpoints, contrary to reported data

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

News and commentary from the world of neurology and neuroscience

Sugar Rationing in Early Life Linked to Lower Dementia Risk Decades Later

Long-term study looks at what happened when sugar was scarce

FDA Committee Votes Down Duchenne Drug

Agency staff and drug developer disagree on endpoints

Alzheimer's Paper Retracted; MS Before Epstein-Barr Infection; Brain Aging Map

News and commentary from the world of neurology and neuroscience

Fauci Successor Imminent; CDC Expands Outbreak List; Pesticides Linked to ALS

Health news and commentary gathered by MedPage Today staff

FDA Approves First-in-Class Narcolepsy Drug

Oveporexton treats more than symptoms, restores orexin signaling

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

Assisted Dying Under Scrutiny From Medscape's Readers

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.

3.

Survival rates for incurable larynx cancer investigated for first time

4.

NPM1-Mutated AML: Not All Treatments Are Equal

5.

Novel Agent for Chronic GVHD Wins FDA Approval

1.

Quality of Life Following Organ Function Preserving Oncologic Innovation

2.

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms

3.

Prognostic Trajectories of Functional Recovery Following Major Hematologic Disorders

4.

Interpreting Iron Studies: What Your Blood Results Really Mean

5.

Digital Oncology Command Platforms for Longitudinal Cancer Care Coordination

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

4.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

5.

How Multidisciplinary Teams Support Modern Cancer Care

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Reducing calories may help cognitive function in MS

Latest News

Ionis Pharma Prices First FDA-approved Treatment for Alexander Disease At $285,000 Per Dose

New Migraine Prevention Guidelines Released

Novartis Pauses Trials Of Experimental Cell Therapy After Three Deaths

Cerebral Palsy Linked to Gaps in Gynecologic Care

Borderline Personality: Evidence Has Evolved. Care Hasn’t

New Stroke Rehab Guideline Calls for Earlier, Broader Care

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Latest News

News All Time

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

FDA Approves Tylenol With Naproxen Combination

FDA Panel Finds a Peptide It Doesn't Like

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

First-in-Class Drug for ADHD Wins FDA Approval

FDA Scientists Raise Questions About Duchenne Drug

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

Sugar Rationing in Early Life Linked to Lower Dementia Risk Decades Later

FDA Committee Votes Down Duchenne Drug

Alzheimer's Paper Retracted; MS Before Epstein-Barr Infection; Brain Aging Map

Fauci Successor Imminent; CDC Expands Outbreak List; Pesticides Linked to ALS

FDA Approves First-in-Class Narcolepsy Drug

Recommended News For You

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

Study: For predicting breast cancer, AI performs better than traditional risk models.

Ruxolitinib Reduces Acute GVHD in Transplant Patients

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

Assisted Dying Under Scrutiny From Medscape's Readers

Recommended Articles For You

Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship

Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients

The Growing Challenge of Haematological Malignancies in Older Adults

Prognostic Trajectories of Functional Recovery During Cancer Survivorship

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.